Work

Phase I Trial of the Antivascular Agent Combretastatin A4 Phosphate on a 5-Day Schedule to Patients With Cancer: Magnetic Resonance Imaging Evidence for Altered Tumor Blood Flow

Year: 2003

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2003.12.986

Authors: James P. Stevenson, Mark Rosen, Weijing Sun, Maryann Gallagher, Daniel G. Haller, David Vaughn, Bruce Giantonio, Ross Zimmer, William P. Petros, Michael Stratford, David Chaplin, Scott L. Young, Mitchell Schnall, Peter J. O’Dwyer

Institution: University of Pennsylvania

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2152961487

FWCI: 5.254

Cites: 38

Cited by: 291

Related to: 10